Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALGS | AMGN | VRTX | REGN | GSK |
| Company | Aligos Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.6500 | 308.47 | 449.58 | 985.43 | 45.75 |
| High | 0.6900 | 311.99 | 453.71 | 991.71 | 45.77 |
| Low | 0.5966 | 304.38 | 446.67 | 975.73 | 44.94 |
| Last | 0.6000 | 306.50 | 450.80 | 980.57 | 45.15 |
| Change | -0.0590 | -2.91 | +3.27 | -3.23 | -0.63 |
| % Change | -8.95% | -0.94% | +0.73% | -0.33% | -1.38% |
| Volume | 638,300 | 2,139,600 | 1,554,800 | 315,700 | 5,218,576 |
| 20-Day Average Volume | 240,635 | 2,869,420 | 1,143,890 | 437,365 | 3,957,555 |
| Previous Close | 0.6590 | 309.41 | 447.53 | 983.80 | 45.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7282 | 301.44 | 421.56 | 956.31 | 44.07 |
| 20-Day Raw Stochastic | 1.24% | 71.69% | 95.31% | 85.89% | 84.67% |
| 20-Day Relative Strength | 34.88% | 58.24% | 72.12% | 58.80% | 62.46% |
| Weighted Alpha | -54.16 | +37.37 | +38.21 | +34.21 | +35.34 |
| Today's Opinion | 40% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 40% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 40% Buy | 40% Sell | 8% Buy | 24% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.40% since 05/16/24 | -2.61% since 05/16/24 | +2.31% since 05/16/24 | +1.30% since 05/16/24 | +0.60% since 05/16/24 |
| Low | 0.5966 on 05/23/24 | 304.38 on 05/23/24 | 437.46 on 05/21/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 0.7545 on 05/17/24 | 316.67 on 05/21/24 | 453.71 on 05/23/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -27.15% since 04/23/24 | +12.05% since 04/23/24 | +11.33% since 04/23/24 | +8.07% since 04/23/24 | +9.48% since 04/23/24 |
| Low | 0.5966 on 05/23/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.63 on 04/24/24 |
| High | 0.8710 on 05/02/24 | 322.60 on 05/03/24 | 453.71 on 05/23/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -20.00% since 02/23/24 | +5.99% since 02/23/24 | +4.81% since 02/23/24 | -0.06% since 02/23/24 | +6.94% since 02/23/24 |
| Low | 0.5966 on 05/23/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.2000 on 03/04/24 | 322.60 on 05/03/24 | 453.71 on 05/23/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -11.76% since 11/22/23 | +15.84% since 11/22/23 | +27.62% since 11/22/23 | +22.61% since 11/22/23 | +28.27% since 11/22/23 |
| Low | 0.5438 on 12/11/23 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 1.2000 on 03/04/24 | 329.72 on 02/05/24 | 453.71 on 05/23/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,474 | 165,978,352 | 115,486,464 | 108,400,976 | 94,876,304 |
| Shares Outstanding, K | 78,110 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 15,530,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -87,680,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 990,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -34,860,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 2.37 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.88 | 29.61 | 26.60 | 11.04 |